Navigation Links
SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres
Date:5/28/2008

SAN DIEGO, May 28 /PRNewswire/ -- SoluLinK, Inc., a leader in next-generation conjugation products and kits, is proud to announce the introduction of a new product, NanoLink(TM) Streptavidin Magnetic Microspheres. These sub-micron particles possess the highest biotin-binding capacity of any commercially available polymer-encapsulated streptavidin magnetic microsphere. NanoLink(TM) Streptavidin particles are particularly suited for high throughput robotic applications where high biotin loads must be removed or immobilized without the presence of an iron leachate. Features and Benefits include:

-- Highest free-biotin binding capacity > 12 nmol/mg

-- Highest biotin-oligonucleotide binding capacity > 2.5 nmol/mg

-- Highest biotin-IgG binding capacity > 1.7 nmol/mg (250 ug)

-- Higher capacity means less mass and lower background (NSB)

-- Higher capacity means significantly lower net costs

-- Encapsulated (no exposed iron) polymeric microspheres

-- Fast magnetic response time (1-2 minutes)

(Photo: http://www.newscom.com/cgi-bin/prnh/20080528/LAW512)

"NanoLink(TM) Streptavidin Magnetic Microspheres represent a continuation of our development efforts in leveraging SoluLinK's next-generation conjugation technology into formats that enable our customers' and collaborators' to build greater value into their products and research," observed Leo Mendoza, Director of Product Development.

About SoluLinK

SoluLinK is a leader in the development, manufacturing and marketing of advanced conjugation reagents (HydraLink(TM)) biotinylation kits (ChromaLink(TM)), magnetic microspheres (NanoLink(TM)), detection reagents and conjugating services for the life sciences, diagnostic, and pharmaceutical communities. The company's proprietary bioconjugation chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK's products include the conjugation of biomolecules used in research assays, diagnostics, and various pharmaceutical products. The company markets its products directly and through partner-associated distributors world-wide. Technology licenses are available. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.


'/>"/>
SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
5. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
6. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
7. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
8. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
9. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
10. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
11. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
Breaking Biology News(10 mins):